ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 051

Pediatric Providers’ Perspectives on Suspected Immune-Mediated Diffuse Alveolar Hemorrhage and Clinical Care Pathways

Jessica Bloom1 and Robert Fuhlbrigge 2, 1Children's Hospital Colorado, Aurora, Colorado, 2University of Colorado, Aurora

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: alveolitis, Clinical practice guidelines, evidence-based practice, pulmonary complications, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Session Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Immune-mediated diffuse alveolar hemorrhage (iDAH) is a life-threatening complication of pediatric rheumatologic diseases such as vasculitis, systemic lupus erythematosus, and antiphospholipid antibody syndrome. Delay in diagnosis and treatment can lead to significant morbidity and mortality, yet the approach to care varies widely with limited evidence to aid decision making. Clinical Care Pathways (CCPs) can support clinicians through diagnosis and management decisions. The purpose of this study was to understand the perspectives of care providers and medical leadership on iDAH and CCPs in order to guide development of an effective clinical tool for these cases.

Methods: 25 semi-structured interviews of key stakeholders were conducted with iterative prompts based on responses. Interviewees were selected by purposeful and snowball sampling and recruited via email. Each interview was audio-recorded and partially transcribed. Interviewees spanned multiple specialties at a single center in Colorado involved in the care of patients with iDAH and included physicians, advanced care providers, hospital leadership, and a parent (Figure 1). Interviews focused on the interviewee’s professional role, general sentiments regarding iDAH, and opinions on CCPs. Common themes were identified using strategies from thematic analysis.

Results: Multiple themes and sub-themes emerged during the interviews, which lasted around 22 minutes on average. In regards to caring for patients with iDAH, interviewees recognized the following three themes: 1) fear of patient decompensation, making the wrong decision, or not recognizing the etiology; 2) the value of personal expertise when lacking evidence; and 3) the lack of clarity surrounding consults such as determining need, appropriate timing, and communication strategies. Two themes arose regarding CCPs: a preference for multidisciplinary, evidence-based tools with room to deviate and the unique benefits of CCPs for rare diseases such as improving knowledge gaps, comfort level, and care coordination (See Tables 1 and 2 for representative quotes). Unforseen concerns included the high resource utilization and dissemination challenges of a less frequently used product. Overall, providers were in favor of a carefully-developed CCP for iDAH.

Conclusion: Providers agree that the current approach to caring for patients with suspected-iDAH is imperfect and have largely favorable perspectives on CCPs as a means of improving such care. Based on these results, a multi-disciplinary, evidence-based pathway for iDAH may provide the sense of support, institutional consensus, and consult clarification desired to address a provider’s needs and ultimately lead to more effective patient care.


Disclosure: J. Bloom, None; R. Fuhlbrigge, None.

To cite this abstract in AMA style:

Bloom J, Fuhlbrigge R. Pediatric Providers’ Perspectives on Suspected Immune-Mediated Diffuse Alveolar Hemorrhage and Clinical Care Pathways [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/pediatric-providers-perspectives-on-suspected-immune-mediated-diffuse-alveolar-hemorrhage-and-clinical-care-pathways/. Accessed June 29, 2022.
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pediatric-providers-perspectives-on-suspected-immune-mediated-diffuse-alveolar-hemorrhage-and-clinical-care-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies